﻿<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Explor Musculoskeletal Dis</journal-id>
<journal-id journal-id-type="publisher-id">EMD</journal-id>
<journal-title-group>
<journal-title>Exploration of Musculoskeletal Diseases</journal-title>
</journal-title-group>
<issn pub-type="epub">2836-6468</issn>
<publisher>
<publisher-name>Open Exploration Publishing</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.37349/emd.2025.1007113</article-id>
<article-id pub-id-type="manuscript">1007113</article-id>
<article-categories>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Xanthoma simulating gouty tophus (case report of atypical cholesterol crystal deposition)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1191-5831</contrib-id>
<name>
<surname>Eliseev</surname>
<given-names>Maxim Sergeevich</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing—review &amp; editing</role>
<xref ref-type="aff" rid="I1" />
<xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-6138-9736</contrib-id>
<name>
<surname>Kuzmina</surname>
<given-names>Yanina Igorevna</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8777-7597</contrib-id>
<name>
<surname>Chikina</surname>
<given-names>Maria Nikolaevna</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing—original draft</role>
<xref ref-type="aff" rid="I1" />
</contrib>
<contrib contrib-type="editor">
<name>
<surname>Pérez-Ruiz</surname>
<given-names>Fernando</given-names>
</name>
<role>Academic Editor</role>
<aff>Cruces University Hospital, Spain</aff>
</contrib>
</contrib-group>
<aff id="I1">V.A. Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia</aff>
<author-notes>
<corresp id="cor1">
<bold>
<sup>*</sup>Correspondence:</bold> Maxim Sergeevich Eliseev, V.A. Nasonova Research Institute of Rheumatology, 34A Karshirskoe shosse, 115522 Moscow, Russia. <email>elicmax@yandex.ru</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>12</month>
<year>2025</year>
</pub-date>
<volume>3</volume>
<elocation-id>1007113</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>12</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2025.</copyright-statement>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract>
<p id="absp-1">The most common clinical manifestation of hyperlipidemia is the formation of xanthomas, which are most often localized subcutaneously, sometimes involving tendons and ligaments, and are usually asymptomatic. A fairly rare manifestation of hyperlipidemia is hypercholesterolemic arthritis caused by cholesterol crystals. In this article, we present a case of atypical xanthoma formation in a patient in the area of the first metatarsophalangeal joint, which resembled a gouty tophus. Taking into account the presence of hyperuricemia in the blood and the “classic” lesion of the first metatarsophalangeal joint, gout was primarily suspected in the patient. The diagnosis of arthritis associated with cholesterol crystals was confirmed using the “gold standard” diagnosis of microcrystalline arthritis—crystal detection using polarization microscopy. This case gives a clear idea of how important it is not to rely solely on the clinical picture when diagnosing gout.</p>
</abstract>
<kwd-group>
<kwd>case report</kwd>
<kwd>cholesterol crystals</kwd>
<kwd>hyperlipidemia</kwd>
<kwd>gout</kwd>
<kwd>tophus</kwd>
<kwd>polarization microscopy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p id="p-1">Gout is a chronic systemic disease caused by the deposition of monosodium urate (MSU) crystals in organs and tissues in individuals with elevated serum uric acid (sUA) levels [hyperuricemia (HU)]. This occurs due to genetic and environmental factors, and clinically manifests itself as acute attacks of arthritis. A “classic” gout attack, with its typical symptoms of severe pain, swelling and redness primarily in the joints of the feet, usually raises few doubts about the diagnosis. However, the diagnosis should be based not only on clinical presentation but also confirmed by laboratory and instrumental testing, especially when acute arthritis may be associated with a bacterial infection. Obtaining synovial fluid or tophus contents and subsequent evaluation of the obtained material under a polarizing microscope is the preferred diagnostic method. This is indeed crucial, as definitive proof of gout depends on the detection of MSU crystals in the synovial fluid. But what we might consider a “classic” manifestation of gout is not always so.</p>
<p id="p-2">Hyperlipidemia is characterized by elevated levels of one or more plasma lipids (triglycerides, cholesterol, cholesterol esters, phospholipids) and/or plasma lipoproteins [very-low-density lipoproteins (VLDL) and low-density lipoproteins (LDL)], and/or reduced levels of high-density lipoproteins (HDL) [<xref ref-type="bibr" rid="B1">1</xref>]. Depending on the etiology, hyperlipidemia can be classified into primary (familial or hereditary) and secondary (acquired) types. Hyperlipidemia is typically asymptomatic, although there are cases where hypercholesteremic arthritis can occur, which is a type of microcrystalline arthritic [<xref ref-type="bibr" rid="B2">2</xref>]. One of the visual clinical manifestations of hyperlipidemia is the presence of yellowish xanthoma deposits, which consist of lipids and are found within foamy macrophage cells and collagen, typically located around the eyes, tendons, and extensor surfaces of the limbs [<xref ref-type="bibr" rid="B3">3</xref>]. Differential diagnosis of xanthomas is carried out with benign skin formations such as syringoma, elastic pseudodoxanthoma, and in the area of tendons and ligaments, it is more often necessary to differentiate between lipomas, subcutaneous cysts, neurofibromas, and gouty tophi, although differential diagnosis with the latter is quite rare.</p>
</sec>
<sec id="s2">
<title>Timeline</title>
<p id="p-3">We report a case of a solitary, massive xanthoma located on the first toe of the left foot, mimicking a gouty tophus, in a patient with hyperlipidemia and asymptomatic HU. This study complies with the Declaration of Helsinki (2013).</p>
<p id="p-4">The timeline is shown in <xref ref-type="table" rid="t1">Table 1</xref>.</p>
<table-wrap id="t1">
<label>Table 1</label>
<caption>
<p id="t1-p-1">
<bold>Timeline.</bold>
</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th>
<bold>Date</bold>
</th>
<th>
<bold>Event overview</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>2017</td>
<td>Injury in the area of the 1st toe and the formation of a seal, a slow increase in the size of the node, which was asymptomatic until September 2024</td>
</tr>
<tr>
<td>2024-09-04</td>
<td>The appearance of pain in the area of 1 MTPJ</td>
</tr>
<tr>
<td>2024-09-06</td>
<td>Ulceration of the node, consultation with a traumatologist</td>
</tr>
<tr>
<td>2024-09-09</td>
<td>Consultation with a rheumatologist, instrumental and laboratory examination</td>
</tr>
<tr>
<td>2024-09-16</td>
<td>Verification of diagnosis and prescription of therapy</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p id="t1-fn-1">MTPJ: metatarsophalangeal joint.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3">
<title>Narrative</title>
<p id="p-5">A 49-year-old patient first applied to the V.A. Nasonova Research Institute of Rheumatology in September 2024 with complaints of pain in the area of the first toe of the left foot (25 mm on the visual analog scale) and discomfort when walking. In 2017, at the age of 42, he suffered a soft tissue injury to the first toe of his left foot (he stepped on a nail). Subsequently, he developed a thickening of the soft tissues and the formation of subcutaneous nodules at the site of the injury, which slowly increased in size. In early September 2024, there was a dull pain in the area of the first metatarsophalangeal joint (MTPJ), followed by spontaneous opening of the node with the discharge of white exudate. The surgeon suspected the patient had gout and referred him to a rheumatologist.</p>
<p id="p-6">A subcutaneous, nodular lesion up to 3 cm in diameter with a small ulcerated surface (site of spontaneous drainage) was noted on the plantar aspect of the left first MTPJ (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<fig id="fig1" position="float">
<label>Figure 1</label>
<caption>
<p id="fig1-p-1">
<bold>Photo of the patient’s left foot before arthrocentesis.</bold> A subcutaneous nodule is visible in the area of the first MTPJ (metatarsophalangeal joint), resembling a tophus.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emd-03-1007113-g001.tif" />
</fig>
<p id="p-7">There was moderate pain on palpation in the area of the first MTPJ; no other inflamed joints or subcutaneous formations were found. Complete blood count was within normal limits; ESR: 18 mm/h; sUA: 7.43 mg/dL; creatinine: 86 µmol/L; GFR was 91 mL/min/1.73 m<sup>2</sup>.</p>
</sec>
<sec id="s4">
<title>Diagnostics</title>
<p id="p-8">Radiography revealed no destructive changes, but a large radiolucent lesion and soft tissue compaction were detected in the area of the first toe of the left foot. Ultrasound of the feet showed no signs of gout. The subcutaneous lesion projecting under the head of the first metatarsal bone was an extensive, non-vascular, multiloculated bursitis containing heterogeneous material.</p>
<p id="p-9">A puncture of the node yielded 2.5 mL of whitish-yellow fluid. Polarized light microscopy revealed colorless, notched plate-like crystals consistent with cholesterol crystals (<xref ref-type="fig" rid="fig2">Figure 2</xref>); no other types of crystals were identified.</p>
<fig id="fig2" position="float">
<label>Figure 2</label>
<caption>
<p id="fig2-p-1">
<bold>Cholesterol crystals viewed under a polarization microscope.</bold> Polarization microscopy by microscope Olympus СХ31-Р, Japan, ×400.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="emd-03-1007113-g002.tif" />
</fig>
<p id="p-10">Lipid profile: total cholesterol 315 mg/dL; triglycerides 784 mg/dL; non-HDL cholesterol 284 mg/dL. Carotid artery ultrasound showed stable atheroscleotic plaque with calcium in right common carotid bifurcation with stenosis up to 26% without hemodynamic effect. Lower limb arterial ultrasound revealed forming plaque in femoral bifurcates with stenosis up to 30%.</p>
<p id="p-11">Gout was excluded based on the results of the examination. Arthritis associated with cholesterol crystals and asymptomatic HU was verified.</p>
</sec>
<sec id="s5">
<title>Patient perspective</title>
<p id="p-12">The patient was under the supervision of a cardiologist and was prescribed fenofibrate at a dose of 145 mg per day. The tolerability of the therapy was satisfactory, but after 4 months, the patient was lost to follow-up.</p>
</sec>
<sec id="s6">
<title>Discussion</title>
<p id="p-13">Our case demonstrates that, even with characteristic symptoms, it is important to take a critical approach when making a diagnosis of gout and conducting differential diagnosis. In our case, we initially suspected gout based on the clinical symptoms alone: an elevated sUA level and the presence of a nodule in the area of the first MTPJ, which are very similar to subcutaneous tophi. Although the patient had no typical acute attacks of arthritis and the symptoms were limited to mild pain, in some cases, tophi may be the first manifestation of the disease [<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>]. However, although subcutaneous tophi have the highest specificity of all clinical symptoms of gout, it is characterized by low sensitivity [<xref ref-type="bibr" rid="B6">6</xref>], and visualization of tophi-like formations during a physical examination cannot establish a diagnosis unless confirmed by instrumental methods. This case confirms this fact.</p>
<p id="p-14">Polarized light microscopy of the resulting fluid revealed no MSU crystals, but all fields of view were covered with crystals of cholesterol crystals. Cholesterol crystals in synovial fluid are most commonly observed in rheumatoid arthritis [<xref ref-type="bibr" rid="B7">7</xref>], but it may also occur in gout, albeit without diagnostic significance [<xref ref-type="bibr" rid="B8">8</xref>]. Lipid crystals may also be present, distinguishable by their smaller size (1–30 µm) and characteristic Maltese cross appearance, whereas cholesterol crystals measure 5–40 µm and appear as notched plates [<xref ref-type="bibr" rid="B8">8</xref>].</p>
<p id="p-15">HU is often linked to hyperlipidemia, especially hypertriglyceridemia [<xref ref-type="bibr" rid="B9">9</xref>]. However, it can also be associated with cholesterol and its fractions. A five-year cohort study involving 6,476 healthy Japanese adults (aged 30–85 years) demonstrated that for each 1 mg/dL (60 µmol/L) increase in sUA, the risk of elevated LDL rose by 16% in men and 22% in women [<xref ref-type="bibr" rid="B10">10</xref>]. Among the factors contributing to dyslipidemia, elevated sUA was the most significant.</p>
<p id="p-16">Xanthomas are the most common visible sign of hyperlipidemia, usually appearing around the eyes and causing no symptoms. [<xref ref-type="bibr" rid="B11">11</xref>]. Musculoskeletal issues in hyperlipidemia can be symptomless or present as joint pain, tendinitis, mono- or oligoarthritis, or widespread polyarticular disease [<xref ref-type="bibr" rid="B12">12</xref>]. Tendinous xanthomas, often found in the Achilles tendon, are commonly linked to familial or mixed hypercholesterolemia [<xref ref-type="bibr" rid="B13">13</xref>]. Cases of hypercholesteremic arthritis have also been reported [<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>]. One case involved a young woman with arthritis of the small joints of the hands and subcutaneous nodules near inflamed joints, raising suspicion for rheumatoid arthritis or gout. Another case described arthritis in the tarsometatarsal joint of the right foot, without subcutaneous nodules. In both cases, the diagnosis of hypercholesterolemic arthritis was confirmed by detection of lipids in nodule biopsy (first case) [<xref ref-type="bibr" rid="B14">14</xref>] and joint aspiration (second case) [<xref ref-type="bibr" rid="B15">15</xref>], along with hyperlipidemia.</p>
</sec>
<sec id="s7">
<title>Conclusions</title>
<p id="p-17">This case illustrates a rare example of xanthoma localisation in a patient with hyperlipidaemia, without any other typical xantomas. Despite classic features of gout, such as asymptomatic HU and involvement of the first MTPJ, polarising microscopy was essential for diagnosis. This case emphasises the importance of testing synovial fluid in the differential diagnosis of suspected microcrystalline arthritis.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>HDL</term>
<def>
<p>high-density lipoproteins</p>
</def>
</def-item>
<def-item>
<term>HU</term>
<def>
<p>hyperuricemia</p>
</def>
</def-item>
<def-item>
<term>LDL</term>
<def>
<p>low-density lipoproteins</p>
</def>
</def-item>
<def-item>
<term>MSU</term>
<def>
<p>monosodium urate</p>
</def>
</def-item>
<def-item>
<term>MTPJ</term>
<def>
<p>metatarsophalangeal joint</p>
</def>
</def-item>
<def-item>
<term>sUA</term>
<def>
<p>serum uric acid</p>
</def>
</def-item>
</def-list>
</glossary>
<sec id="s8">
<title>Declarations</title>
<sec id="t-8-1">
<title>Author contributions</title>
<p>MSE: Conceptualization, Supervision, Writing—review &amp; editing. YIK: Conceptualization, Investigation, Writing—original draft. MNC: Investigation, Writing—original draft. All authors read and approved the submitted version.</p>
</sec>
<sec id="t-8-2" sec-type="COI-statement">
<title>Conflicts of interest</title>
<p>The authors declare that they have no conflicts of interest.</p>
</sec>
<sec id="t-8-3">
<title>Ethical approval</title>
<p>The work was carried out by the study “Development of approaches to phenotyping autoinflammatory degenerative rheumatic diseases based on a comparative study of biochemical, immunological and genetic factors associated with the state of bone, cartilage, muscle and adipose tissue” No. 125020501433–4. The study was approved by the local ethics committee at the V.A. Nasonova Research Institute of Rheumatology. This study complies with the Declaration of Helsinki (2013).</p>
</sec>
<sec id="t-8-4">
<title>Consent to participate</title>
<p>Informed consent to participate in the study was obtained from the participant.</p>
</sec>
<sec id="t-8-5">
<title>Consent to publication</title>
<p>The patient has been informed about this publication, and he gave written consent.</p>
</sec>
<sec id="t-8-6" sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.</p>
</sec>
<sec id="t-8-7">
<title>Funding</title>
<p>Not applicable.</p>
</sec>
<sec id="t-8-8">
<title>Copyright</title>
<p>© The Author(s) 2025.</p>
</sec>
</sec>
<sec id="s9">
<title>Publisher’s note</title>
<p>Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.</p>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Bordoni</surname>
<given-names>B</given-names>
</name>
</person-group>
<source>Hyperlipidemia</source>
<publisher-loc>Treasure Island (FL)</publisher-loc>
<publisher-name>StatPearls Publishing</publisher-name>
<year iso-8601-date="2025">2025</year>
<pub-id pub-id-type="pmid">32644608</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coiffier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Albert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Guggenbuhl</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Acute phospholipid microspherule associated arthritis: Is it rare?</article-title>
<source>Joint Bone Spine</source>
<year iso-8601-date="2017">2017</year>
<volume>84</volume>
<fpage>537</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/j.jbspin.2016.11.001</pub-id>
<pub-id pub-id-type="pmid">27989588</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morales</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Dominguez</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Sreepad</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sheu</surname>
<given-names>AJ</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>The importance of dermatological detection of xanthomas and xanthelasmas in pediatric patients: A literature review</article-title>
<source>JAAD Reviews</source>
<year iso-8601-date="2025">2025</year>
<volume>4</volume>
<fpage>149</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1016/j.jdrv.2025.03.010</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salavastru</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Copaci</surname>
<given-names>FI</given-names>
</name>
<name>
<surname>Vrinceanu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sendrea</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Tiplica</surname>
<given-names>GS</given-names>
</name>
</person-group>
<article-title>Tophaceous Gout - When the Skin Comes First</article-title>
<source>Acta Dermatovenerol Croat</source>
<year iso-8601-date="2020">2020</year>
<volume>28</volume>
<fpage>223</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">33834994</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bieber</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schlesinger</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fawaz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mader</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Chronic tophaceous gout as the first manifestation of gout in two cases and a review of the literature</article-title>
<source>Semin Arthritis Rheum</source>
<year iso-8601-date="2018">2018</year>
<volume>47</volume>
<fpage>843</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.semarthrit.2017.11.006</pub-id>
<pub-id pub-id-type="pmid">29275830</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="book">
<source>Evidence review for what signs and symptoms indicate gout as a possible diagnosis? Gout: diagnosis and management</source>
<publisher-loc>London</publisher-loc>
<publisher-name>National Institute for Health and Care Excellence (NICE)</publisher-name>
<year iso-8601-date="2022">2022</year>
<pub-id pub-id-type="pmid">36063472</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliviero</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mandell</surname>
<given-names>BF</given-names>
</name>
</person-group>
<article-title>Synovial fluid analysis: Relevance for daily clinical practice</article-title>
<source>Best Pract Res Clin Rheumatol</source>
<year iso-8601-date="2023">2023</year>
<volume>37</volume>
<elocation-id>101848</elocation-id>
<pub-id pub-id-type="doi">10.1016/j.berh.2023.101848</pub-id>
<pub-id pub-id-type="pmid">37429800</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dieppe</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Swan</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Identification of crystals in synovial fluid</article-title>
<source>Ann Rheum Dis</source>
<year iso-8601-date="1999">1999</year>
<volume>58</volume>
<fpage>261</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1136/ard.58.5.261</pub-id>
<pub-id pub-id-type="pmid">10225806</pub-id>
<pub-id pub-id-type="pmcid">PMC1752883</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>The association between serum uric acid and hypertriglyceridemia: evidence from the national health and nutrition examination survey (2007-2018)</article-title>
<source>Front Endocrinol (Lausanne)</source>
<year iso-8601-date="2023">2023</year>
<volume>14</volume>
<elocation-id>1215521</elocation-id>
<pub-id pub-id-type="doi">10.3389/fendo.2023.1215521</pub-id>
<pub-id pub-id-type="pmid">37534213</pub-id>
<pub-id pub-id-type="pmcid">PMC10392824</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuwabara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Borghi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cicero</surname>
<given-names>AFG</given-names>
</name>
<name>
<surname>Hisatome</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Niwa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ohno</surname>
<given-names>M</given-names>
</name>
<etal>et al.</etal>
</person-group>
<article-title>Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan</article-title>
<source>Int J Cardiol</source>
<year iso-8601-date="2018">2018</year>
<volume>261</volume>
<fpage>183</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijcard.2018.03.045</pub-id>
<pub-id pub-id-type="pmid">29551256</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Al</surname>
<given-names>Aboud AM</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Al</surname>
<given-names>Aboud DM</given-names>
</name>
</person-group>
<source>Xanthelasma Palpebrarum</source>
<publisher-loc>Treasure Island (FL)</publisher-loc>
<publisher-name>StatPearls</publisher-name>
<year iso-8601-date="2025">2025</year>
<pub-id pub-id-type="pmid">30285396</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gagné</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brun</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lupien</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Moorjani</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Articular manifestations of familial hypercholesterolaemia</article-title>
<source>Ann Rheum Dis</source>
<year iso-8601-date="1985">1985</year>
<volume>44</volume>
<fpage>599</fpage>
<lpage>602</lpage>
<pub-id pub-id-type="doi">10.1136/ard.44.9.599</pub-id>
<pub-id pub-id-type="pmid">4037885</pub-id>
<pub-id pub-id-type="pmcid">PMC1001717</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klemp</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Halland</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Majoos</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Steyn</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Musculoskeletal manifestations in hyperlipidaemia: a controlled study</article-title>
<source>Ann Rheum Dis</source>
<year iso-8601-date="1993">1993</year>
<volume>52</volume>
<fpage>44</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1136/ard.52.1.44</pub-id>
<pub-id pub-id-type="pmid">8427513</pub-id>
<pub-id pub-id-type="pmcid">PMC1004954</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Padhan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Pradhan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mohanty</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Hypercholesterolemic arthritis in a young female</article-title>
<source>Eur J Rheumatol</source>
<year iso-8601-date="2020">2020</year>
<volume>7</volume>
<fpage>96</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.5152/eurjrheum.2019.19033</pub-id>
<pub-id pub-id-type="pmid">31329537</pub-id>
<pub-id pub-id-type="pmcid">PMC7250478</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugimoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sakuda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hirata</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Cholesterol Crystal-induced Arthritis</article-title>
<source>Intern Med</source>
<year iso-8601-date="2025">2025</year>
<volume>64</volume>
<fpage>1946</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.2169/internalmedicine.4500-24</pub-id>
<pub-id pub-id-type="pmid">39566984</pub-id>
<pub-id pub-id-type="pmcid">PMC12241773</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>